Celgene to Use Cypher Genomics’ Data Analytics in Drug Development

May 20, 2015 | Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey's Celgene identify key genetic variants among patients who respond well to specific drugs. Xconomy